Only cancer drugs/vaccines would do better in term of moving the stock up North. INO needs to move their VGX-3100 to P3 study as soon as they could to move the sp back to mid-10 or $20 range. At this current stage, they seem not to worry...why? HFs are their friends? Takes time so the HFs can gradually cover...
Infectious disease won't help the sp much...This is the fact b/c they probably not making any Rev $$. Stock is valued by any meaningful potential Rev
Meeting w/ FDA in early 2016, it would take FDA up to 90 days to say ok or needs more...so I think the P3 would start in summer of 2016 is the earliest. Getting the nod from FDA for P3 study is consider a success. INO needs to get into p3 to stabilize the sp and move it back to mid-10.
Progress on 3112 and milestones payment from MedIm and Roche will add to the fuel..
Secretary of Health and Human Services Sylvia Mathews Burwell said Friday that high drug prices are “a problem we must solve” as she kicked off an administration forum on the topic.
“We know that too many Americans struggle to afford the medications they need,” she said. “A recent Kaiser survey showed that almost a quarter of Americans have skipped filling a prescription over the last year.”
“With an explosion of innovation, we have the opportunity to find new medicines, therapies and cures,” she said. “We have the chance to improve the quality of life for those suffering from diseases today and help prevent many more.”
INO's vaccines could be the nice fix, but they need to have that kind of urgency, keep delaying the trials,test/data are not the good way of doing busisness.
This news is all about FDA ok to go ahead of P1 study on human which is very encouraged news. Looks like they still schedule to start the trial in this qtr. Let's hope there will be no 'delay'. This is the only catalyst for this 2015....
I am only speaking the Fact that this management lead by Dr Kim will soon fail the company where the techs look so promising and could help million of patient in time manner
He could wait for 5-10 years to get the 1st product out, but we can't, cancer patient can't
I am asking for him to resign as the CEO as look more likely he just simply can't handle it
Can't say better than that. This management lead by Dr Kim is BS
Kim, you need to take all the $ and go back to South Korea and still live like a king. Sell this company to someone who can make it work for the benefit of the human being...
No, that is not truth. they said will meeting w/ FDA regarding P3 permission. it will then take FDA up to 3 months to say yes or may require more data/test/trial...so I am not surprise p3 could start end of 2016
they may have over 100M shares prior to start 1st P3 study. Lie/delay/dilution/rs...
I am so tired of them saying bs
The only thing they did is delay. Now with lot of cash in the bank, they will slow everything down....and still make super good living out of the stock holders. Bs
I am no surprised here. INO Management kept misleading investors, delayed one after another...allowing their HF Shorts making ton of money out of this stock.
I am long here but very mad and disappointed the way this Mngt have been treated retail investors.
I am strongly vote for Dr Kim to step down as the CEO. He must back in the Lab where he is at his best
Alex, it was in the Investor Presentation, under Value Drivers and Milestones. It was said Hep C interim P1 data supposed to be released in Q4, 15. It's now updated to 2015/Early 2016 = Delaying
Early 2016 could be Jan or Feb or March...
Just as I was excited to hear about P1 Ebola data this qtr - the 1st testing on Human - and bang, they delayed it w/ no explanation. I am now more and more believing this INO's Mngt have 0 care of our retail investors...They have big check deliver to their account for at least 3 more years....Maybe this Joe guy is right and he has some good points as well.
VJ - look at NVAX. They may not have the best 'potential' like INO, but they have what they said...The Streets love them, a lot. We invested to make $$ first and formost...
Step down as the CEO if you can't handle it for any reasons. Or sell it to the BP.
we're human being somehow, someway need vaccine as soon as possible. We just can't afford to wait for next 4-5 years to have the 1st one out...Please take it seriously
Maybe Kim 'chi' has the data, but purposely delayed to realeas it so his Short friends have time to cover or short more...That is one of the main reason why The Streets still don't have any love for this Renovation Vaccince company...
While I was trying to find any excuses for delaying P3 VGX-3100 meeting w/ FDA, I can't find any reasons for delaying others like ebola, or Hep C data. They have already said last qtr that they will be realeasing those data this Q4, but now what???
I agree, this bs mngt have been slept w/ the Shorts for too long.
Looks like we have no study data to hear for the next 2 or 3 or 4 or 5 or 6 months. Seem the HF shorts knew it in advance...whom agreed to buy chunk of shares at $8
VGX-3100 meeting w/ FDA = Delay
Ebola P1 data = delay
Hep C interim data = delay.
So disappointed w/ the current management. Looks like they will take 4 weeks off for Holidays?